- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.2 Consulting Agreement and Release
- 10.2 Restricted Stock Agreement
- 10.2 Lock-up Agreement
- 10.2 Proprietary Information and Inventions Agreement
- 10.3 Proprietary Information and Inventions Agreement
- 10.8 Amendment to 2014 Stock Incentive Plan
- 14 Code of Ethics
- 21 List of Subsidiaries of Ohr Pharmaceutical. Inc.
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer
- 31.2 Chief Financial Officer and Principal Accounting Officer
- 32.1 Certification of Chief Executive Officer
- 32.2 Chief Financial Officer and Principal Accounting Officer
- Download Excel data file
- View Excel data file
Exhibit 10.8(b)
FIRST AMENDMENT
TO
OHR PHARMACEUTICAL, INC.
AMENDED AND RESTATED 2014 STOCK INCENTIVE PLAN
This First Amendment (this “Amendment”) is to be effective as of March 31, 2014.
1. Section 4(a) of the Ohr Pharmaceutical, Inc. 2014 Stock Incentive Plan is amended and restated in its entirety as follows:
“(a)Number of Shares Available for Awards. The shares subject to Awards granted under the Plan shall be 2,750,000 Shares. Such Shares subject to the Plan may be either authorized and unissued Shares (which will not be subject to preemptive rights) or previously issued Shares acquired by the Company or any Affiliate.
2. This Amendment was duly adopted and approved by the Board of Directors of Ohr Pharmaceutical, Inc. (the “Company”) on January 6, 2015 and by the stockholders of the Company on March 10, 2015.